Shell Asset Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,332	Closed	-$14K	–	1155
2025 Q2	$14K	Sell	1,332 -980	-42%	-$12.4K	﹤0.01%	1243
2025 Q1	$35K	Sell	2,312 -97	-4%	-$1.61K	﹤0.01%	1197
2024 Q4	$40K	Hold	2,409	–	–	﹤0.01%	1199
2024 Q3	$60K	Buy	+2,409	New	+$62.5K	﹤0.01%	1154
2024 Q1	$64K	Sell	2,545 -176	-6%	-$4.26K	﹤0.01%	1115
2023 Q4	$62K	Sell	2,721 -779	-22%	-$16.1K	﹤0.01%	1139
2023 Q3	$65K	Sell	3,500 -54	-2%	-$1.12K	﹤0.01%	1158
2023 Q2	$92K	Sell	3,554 -21	-0.6%	-$562	﹤0.01%	1136
2023 Q1	$103K	Sell	3,575 -12	-0.3%	-$357	﹤0.01%	1095
2022 Q4	$106K	Sell	3,587 -354	-9%	-$10.1K	﹤0.01%	1141
2022 Q3	$94K	Sell	3,941 -515	-12%	-$11.9K	﹤0.01%	1251
2022 Q2	$99K	Buy	4,456 +57	+1%	+$1.27K	﹤0.01%	1281
2022 Q1	$110K	Sell	4,399 -650	-13%	-$19.8K	﹤0.01%	1279
2021 Q4	$181K	Buy	5,049 +29	+0.6%	+$1.16K	﹤0.01%	1229
2021 Q3	$214K	Sell	5,020 -220	-4%	-$9.06K	﹤0.01%	1183
2021 Q2	$227K	Sell	5,240 -3,681	-41%	-$157K	﹤0.01%	1199
2021 Q1	$364K	Buy	8,921 +5,117	+135%	+$194K	0.01%	975
2020 Q4	$172K	Hold	3,804	–	–	﹤0.01%	1156
2020 Q3	$135K	Hold	3,804	–	–	﹤0.01%	1120
2020 Q2	$144K	Buy	+3,804	New	+$125K	﹤0.01%	1092

Other funds holding ANIK